- From: Alex Puig <alex@caelumlabs.com>
- Date: Wed, 8 Apr 2020 08:16:31 +0200
- To: "D.W.Chadwick" <info@verifiablecredentials.info>
- Cc: Adrian Gropper <agropper@healthurl.com>, Moses Ma <moses.ma@futurelabconsulting.com>, Christopher Allen <ChristopherA@lifewithalacrity.com>, Credentials Community Group <public-credentials@w3.org>
- Message-ID: <CAHdUGAGPki=JXmzOLOeffpVsotQDoKe9W4V1K4CXs=S3en9z6A@mail.gmail.com>
Thanks!!!
In fact we only need the Subject :)
Alex
El mié., 8 abr. 2020 a las 7:22, D.W.Chadwick (<
info@verifiablecredentials.info>) escribió:
> Hi Alex
>
> here is one for you, without the proof, which is not needed for JWT
>
> {
> "@context": [
> "https://www.w3.org/2018/credentials/v1",
> "https://www.nhs.org/VCcontext/v1"
> ],
> "id": "https://nhs.org/credentials/3732",
> "type": ["VerifiableCredential", "Covid19Immunity"],
> "credentialSubject": {
> "id": "did:key:jwt:ebfeb1f712ebc6f1c276e12ec21",
> "issuanceDate": "2020-04-01T19:23:24Z",
> "expirationDate": "2020-04-01T19:33:24Z",
> "covid19ImmunityCert": {
> "name": "David Chadwick",
> "dateOfBirth": "01/01/1980",
> "dateOfTest": "02/04/2020",
> "testNumber": "376012345612345",
> "testResult": "scientific details here",
> "validUntil": "01/10/2020"
> }
> }
> }
>
>
> Any help with filling in the testResult would be very useful
>
> Kind regards
>
> David
>
> On 08/04/2020 16:34, Alex Puig wrote:
> > For now, a VC example in JSON would do the job.
> >
> > Anyway, we are working with a well known epidemiologist, who can help
> > us on this.
> >
> > Alex
> >
> > El mié., 8 abr. 2020 a las 6:32, D.W.Chadwick
> > (<info@verifiablecredentials.info
> > <mailto:info@verifiablecredentials.info>>) escribió:
> >
> > Hi Alex
> >
> > do you want a VC example in JSON, or a signed example using JWT?
> > These
> > are the only ones I have. If you want a ZKP or JSON-LD signed one you
> > will need to ask someone else.
> >
> > Note that the example we are using is not a medically correct one,
> > but
> > rather is a template that will need to be completed with medical
> > details
> > once these have been standardised. Perhaps Adrian might be able to
> > fill
> > in more details?
> >
> > kind regards
> >
> > David
> >
> > On 08/04/2020 15:58, Alex Puig wrote:
> > > This is relevant to me.
> > >
> > > We are working on an implementation of
> > > https://github.com/DP-3T/documents using Zenroom.
> > >
> > > An immunity credential example would help us.
> > >
> > > Alex
> > >
> > > El mar., 7 abr. 2020 a las 23:27, Adrian Gropper
> > > (<agropper@healthurl.com <mailto:agropper@healthurl.com>
> > <mailto:agropper@healthurl.com <mailto:agropper@healthurl.com>>>)
> > escribió:
> > >
> > > HT to Juan C.
> > > https://unherd.com/2020/04/how-far-away-are-immunity-passports/
> > >
> > > I would ask: IWhat is the role of VC relative to local or
> > > decentralized governance to solving this issue?
> > >
> > > - Adrian
> > >
> > >
> > > On Tue, Apr 7, 2020 at 3:10 PM D.W.Chadwick
> > > <info@verifiablecredentials.info
> > <mailto:info@verifiablecredentials.info>
> > > <mailto:info@verifiablecredentials.info
> > <mailto:info@verifiablecredentials.info>>> wrote:
> > >
> > > Hi Moses
> > >
> > > over the last week or so we have developed a proof of
> > concept
> > > COVID-19
> > > Immunity Certificate application demonstrator built on our
> > > application
> > > independent verifiable credential middleware. We would
> > like to
> > > participate in challenge (1) headed by Victoriano. I am
> > > currently in the
> > > process of making a video of our demo
> > >
> > > Kind regards
> > >
> > > David
> > >
> > > On 08/04/2020 06:51, Moses Ma wrote:
> > > > Hi Christopher et al,
> > > >
> > > > You're absolutely right. This is why we have
> > recruited: Dr. Ab
> > > > Osterhaus to join our team - he is one of the world's
> > > leading experts
> > > > in coronaviruses, and his team was first to sequence the
> > > SARS virus,
> > > > Dr. Tony Cox - a data scientist who specializes in
> > > epidemiology, and
> > > > Triall.io - a clinical research organization that has run
> > > over 30
> > > > Phase I-IV trials and is the developer of the first
> > > blockchain tool
> > > > for clinical trials. All of our proposed pilots will
> > adhere to
> > > > clinical research methodologies that preserve patient
> > > privacy and
> > > > insure validated data production.
> > > >
> > > > However, what we could use more of are privacy experts
> who
> > > can quickly
> > > > produce innovative working solutions.
> > > >
> > > > Two challenges we've identified are: (1) the use of
> > verifiable
> > > > credentials to serve as digital certificates of immunity,
> > > and (2) the
> > > > possibility of developing interoperable contact
> > managers and
> > > globally
> > > > unique IDs to enable international travel. A big thanks
> to
> > > Victoriano
> > > > Giralt for stepping up to manage the first one, but I
> > think
> > > we still
> > > > need to find a MacGyvered approach to solving the
> > second...
> > > in a way
> > > > that has a low barrier to federation and adoption. To be
> > > brutally
> > > > honest, we are triaging a solution, and we need to see
> > > reality clearly
> > > > as to whether DIDs can add value short term.
> > > >
> > > > If you'd like to work on these sub-projects, please let
> me
> > > know.
> > > > Again, this is an action-primary team that will need
> > to deliver
> > > > software on an super-agile basis.
> > > >
> > > > Anyway, I promised to share the recording of our first
> > call
> > > so you
> > > > know what we're up to, and you can find it here:
> > > >
> > >
> >
> https://www.dropbox.com/s/rqhpum88k28usti/Zoom-DefenderDIDcall-040620.mp4?dl=0
> > > >
> > > > Finally, I'll try to make time for CCG calls, but I'm
> > getting
> > > > exponentially busier these days.
> > > >
> > > >
> > > > Stay healthy everyone!
> > > >
> > > > Moses
> > > >
> > > >
> > > > PS, thisis a very interesting article about user
> > acceptance
> > > of contact
> > > > managers:https://045.medsci.ox.ac.uk/user-acceptance -
> > > respondents
> > > > were most concerned about “government using the app as an
> > > excuse to
> > > > increase surveillance after the epidemic”.
> > > >
> > > >
> > > > <https://045.medsci.ox.ac.uk/user-acceptance>
> > > >
> > > > On 4/7/20 10:19 AM, Christopher Allen wrote:
> > > >> As was discussed briefly in the call today, if we are
> > going
> > > to talk
> > > >> about #Covid19 technology solutions, we must partner
> with
> > > health &
> > > >> epidemiological experts to do it right.
> > > >>
> > > >> For instance, it has been proposed that we support some
> > > kind of
> > > >> digital immunity certificate. Even if we ignore its
> > possible
> > > >> human-rights & privacy risks, it can have still have
> > risky
> > > public
> > > >> health care choices:
> > > >>
> > > >>
> > https://unherd.com/2020/04/how-far-away-are-immunity-passports/
> > > >>
> > > >> “If you issue immunity passports on this basis, /barely
> a
> > > third /of
> > > >> the people you give them to will actually be immune.
> > > “There’s nothing
> > > >> peculiar about this statistically,” Kevin McConway, an
> > > emeritus
> > > >> professor of statistics at the Open University, told me.
> > > “It’s just
> > > >> Bayes’ theorem
> > > <https://en.wikipedia.org/wiki/Bayes%27_theorem>.” The
> > > >> likelihood of you having had Covid-19, if you’ve had a
> > > positive test,
> > > >> depends not just on the accuracy of the test but on the
> > > prevalence in
> > > >> the population you’re looking at.
> > > >> …
> > > >> In the end, that’s going to be a horribly cold-blooded
> > > calculation.
> > > >> If you let people out when they’re 90% likely to be
> > immune,
> > > that
> > > >> means one person in 10 is going to be at risk of
> > getting and
> > > >> spreading the disease. Is that risk a price worth paying
> > > for reducing
> > > >> the real costs (economic, social, physical, mental) of
> > > isolation? I
> > > >> don’t know and I’m glad I don’t have to work it out. But
> > > someone has
> > > >> to. And they’ll have to start by getting a reasonably
> > > effective test,
> > > >> and testing hundreds of thousands of people, to see how
> > > many of us
> > > >> have had it.”
> > > >>
> > > >> — Christopher Allen
> > > >
> > > >
> > > > --
> > > >
> > > > *Moses Ma | Managing Partner*
> > > >
> > > > moses.ma@futurelabconsulting.com
> > <mailto:moses.ma@futurelabconsulting.com>
> > > <mailto:moses.ma@futurelabconsulting.com
> > <mailto:moses.ma@futurelabconsulting.com>> | moses@ngenven.com
> > <mailto:moses@ngenven.com>
> > > <mailto:moses@ngenven.com <mailto:moses@ngenven.com>>
> > > >
> > > > v+1.415.568.1068 | skype mosesma |
> > /linktr.ee/moses.tao/ <http://linktr.ee/moses.tao/>
> > > <http://linktr.ee/moses.tao/>
> > > > <http://linktr.ee/moses.tao>
> > > >
> > > > FutureLab provides strategy, ideation and technology for
> > > breakthrough
> > > > innovation and third generation blockchains.
> > > >
> > > > Learn more at /www.futurelabconsulting.com/
> > <http://www.futurelabconsulting.com/>
> > > <http://www.futurelabconsulting.com/>
> > > > <http://futurelabconsulting.com>. For calendar invites,
> > > please cc:
> > > > mosesma@gmail.com <mailto:mosesma@gmail.com>
> > <mailto:mosesma@gmail.com <mailto:mosesma@gmail.com>>
> > > >
> > > >
> > > > Or whet your appetite by reading /Agile Innovation/
> > > >
> > >
> > <
> http://www.amazon.com/Agile-Innovation-Revolutionary-Accelerate-Engagement/dp/B00SSRSZ9A
> >
> > >
> > > > | /Quantum Design Sprint/
> > > >
> > >
> > <
> https://www.amazon.com/Quantum-Design-Sprint-Application-Disruptive/dp/1799143864
> >
> > >
> > > > | my blog at /psychologytoday.com/
> > <http://psychologytoday.com/>
> > > <http://psychologytoday.com/>
> > > > <http://www.psychologytoday.com/blog/the-tao-innovation
> >.
> > > >
> > > > NOTICE TO RECIPIENT: THIS E-MAIL IS MEANT FOR ONLY THE
> > INTENDED
> > > > RECIPIENT OF THE TRANSMISSION. IF YOU RECEIVED THIS
> E-MAIL
> > > IN ERROR,
> > > > ANY REVIEW, USE, DISSEMINATION, DISTRIBUTION, OR
> > COPYING OF
> > > THIS
> > > > E-MAIL IS STRICTLY PROHIBITED. PLEASE NOTIFY THE SENDER
> > > IMMEDIATELY OF
> > > > THE ERROR BY RETURN E-MAIL AND PLEASE DELETE THIS MESSAGE
> > > FROM YOUR
> > > > SYSTEM. THIS EMAIL SHOULD NOT BE CONSIDERED BINDING;
> > HARD COPY
> > > > DOCUMENTS ARE REQUIRED TO CREATE LEGALLY BINDING
> > > COMMITMENTS. FOR
> > > > CALENDAR INVITES, PLEASE CC: MOSESMA@GMAIL.COM
> > <mailto:MOSESMA@GMAIL.COM>
> > > <mailto:MOSESMA@GMAIL.COM <mailto:MOSESMA@GMAIL.COM>>
> > > >
> > >
> > >
> > >
> > > --
> > >
> > > Alex Puig
> > >
> > > CTO
> > >
> > > +34 678544357
> > >
> > > alex@caelumlabs.com <mailto:alex@caelumlabs.com>
> > <mailto:alex@caelumlabs.com <mailto:alex@caelumlabs.com>>
> > >
> > > Follow us!Twitter <https://twitter.com/caelumlabs>|
> > >
> > > linkedin <https://www.linkedin.com/company/caelumlabs/>|
> Newsletter
> > > <http://newsletter.caelumlabs.com/>|Gitlab
> > <https://gitlab.com/caelumlabs>
> > >
> > > IMPORTANT: The contents of this email and any attachments are
> > > confidential. It is strictly forbidden to share any part of this
> > > message with any third party, without a written consent of the
> > sender.
> > > If you received this message by mistake, please reply to this
> > message
> > > and follow with its deletion, so that we can ensure such a mistake
> > > does not occur in the future.
> > >
> > > *
> > >
> > > *
> >
> >
> >
> > --
> >
> > Alex Puig
> >
> > CTO
> >
> > +34 678544357
> >
> > alex@caelumlabs.com <mailto:alex@caelumlabs.com>
> >
> > Follow us!Twitter <https://twitter.com/caelumlabs>|
> >
> > linkedin <https://www.linkedin.com/company/caelumlabs/>| Newsletter
> > <http://newsletter.caelumlabs.com/>|Gitlab <
> https://gitlab.com/caelumlabs>
> >
> > IMPORTANT: The contents of this email and any attachments are
> > confidential. It is strictly forbidden to share any part of this
> > message with any third party, without a written consent of the sender.
> > If you received this message by mistake, please reply to this message
> > and follow with its deletion, so that we can ensure such a mistake
> > does not occur in the future.
> >
> > *
> >
> > *
>
--
Alex Puig
CTO
+34 678544357
alex@caelumlabs.com
Follow us! Twitter <https://twitter.com/caelumlabs> |
linkedin <https://www.linkedin.com/company/caelumlabs/> | Newsletter
<http://newsletter.caelumlabs.com/> | Gitlab <https://gitlab.com/caelumlabs>
IMPORTANT: The contents of this email and any attachments are confidential.
It is strictly forbidden to share any part of this message with any third
party, without a written consent of the sender. If you received this
message by mistake, please reply to this message and follow with its
deletion, so that we can ensure such a mistake does not occur in the future.
Received on Wednesday, 8 April 2020 06:17:15 UTC